Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging ...

OmniaSecure is now the first defibrillation lead approved for placement in the left bundle branch.

Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecure™ defibrillation lead. Now ...

Medtronic recently unveiled its leadless pacemaker, which is still in development. Medtronic unveiled its eagerly anticipated leadless pacemaker at the TEDMED conference last week and already has ...

The placement device for the LivIQ leadless pacemaker. [Image courtesy of Biotronik] Biotronik today announced the initiation ...

The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.

Sixty-seven years ago on Halloween, a rolling power outage wreaked havoc across the Twin Cities and at the University of Minnesota hospital, where cardiac patients were relying on electrical ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. In 1958 Earl Bakken an electrical ...